This cluster groups 2 independently calculated changes: Cash & equivalents increased 17.0%; Operating cash flow increased 27.0%.
2 evidence-backed components· Biological Products, (No Diagnostic Substances)
RESEARCH SNAPSHOTANAVEX LIFE SCIENCES CORP.'s latest supported as-filed period reports net income of $7.8M, 159.1% above the comparable as-filed period. Every value below links to its SEC accession and metric lineage.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
This cluster groups 2 independently calculated changes: Cash & equivalents increased 17.0%; Operating cash flow increased 27.0%.
2 evidence-backed componentsOperating cash flow changed +27.0% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Each point keeps the date investors could first observe it and its accession.
AVXL · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001731122-26-001211SEC ↗8-KSep 2, 2026Period Sep 2, 20260001731122-26-001179SEC ↗10-QAug 28, 2026Period Jun 30, 20260001731122-26-001167SEC ↗10-QAug 28, 2026Period Mar 31, 20260001731122-26-001166SEC ↗10-Q/AAug 28, 2026Period Dec 31, 20250001731122-26-001165SEC ↗10-K/AAug 28, 2026Period Sep 30, 20250001731122-26-001164SEC ↗8-KAug 25, 2026Period Aug 25, 20260001731122-26-001143SEC ↗8-KTransaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| Jan 6, 2026Filed Jan 9, 2026 | MISSLING CHRISTOPHER UPresident and CEO | Grant Or AwardDirect | 125,000 | $0 | $0 | Form 4 ↗ |
| Jan 6, 2026Filed Jan 9, 2026 | Boenisch SandraPFO & Treasurer | Grant Or AwardDirect | 12,500 | $0 | $0 | Form 4 ↗ |
| Oct 2, 2025Filed Oct 3, 2025 | Boenisch SandraPFO & Treasurer | Grant Or AwardDirect | 12,500 | $0 | $0 | Form 4 ↗ |
| Oct 2, 2025Filed Oct 3, 2025 | MISSLING CHRISTOPHER UPresident and CEO | Grant Or AwardDirect | 125,000 | $0 | $0 | Form 4 ↗ |
| Sep 11, 2025Filed Sep 12, 2025 |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Shares outstanding changed +7.9% from the comparable as-filed period. The change ranks at the 71th percentile of 7 prior comparable changes.
Operating income changed +146.6% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Net income changed +159.1% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change. This reverses 2 consecutive comparable moves in the opposite direction.
Cash & equivalents changed +17.0% from the comparable as-filed period.
Total assets changed +17.3% from the comparable as-filed period.
Stock-based compensation changed -495.1% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change. This reverses 2 consecutive comparable moves in the opposite direction.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-06-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001731122-26-001078| MISSLING CHRISTOPHER UPresident and CEO |
| Option ExerciseDirect |
| 187,500 |
| $5 |
| $945,000 |
| Form 4 ↗ |
| Sep 11, 2025Filed Sep 12, 2025 | MISSLING CHRISTOPHER UPresident and CEO | Tax WithholdingDirect | 145,048 | $10 | $1.4M | Form 4 ↗ |
| Sep 11, 2025Filed Sep 12, 2025 | MISSLING CHRISTOPHER UPresident and CEO | Option ExerciseDirect | 187,500 | $0 | $0 | Form 4 ↗ |
| Aug 20, 2025Filed Aug 22, 2025 | Boenisch SandraPFO & Treasurer | Grant Or AwardDirect | 12,500 | $0 | $0 | Form 4 ↗ |
| Aug 20, 2025Filed Aug 22, 2025 | MISSLING CHRISTOPHER UPresident and CEO | Grant Or AwardDirect | 125,000 | $0 | $0 | Form 4 ↗ |
| Jun 5, 2025Filed Jun 9, 2025 | Thomas SteffenDirector | Option ExerciseDirect | 50,000 | $2 | $88,000 | Form 4 ↗ |
| Jun 5, 2025Filed Jun 9, 2025 | Thomas SteffenDirector | Tax WithholdingDirect | 11,349 | $8 | $87,955 | Form 4 ↗ |
| Jun 5, 2025Filed Jun 9, 2025 | Thomas SteffenDirector | Option ExerciseDirect | 50,000 | $0 | $0 | Form 4 ↗ |
| Apr 28, 2025Filed Apr 30, 2025 | Boenisch SandraPFO & Treasurer | Grant Or AwardDirect | 12,500 | $0 | $0 | Form 4 ↗ |
| Apr 28, 2025Filed Apr 30, 2025 | MISSLING CHRISTOPHER UPresident and CEO | Grant Or AwardDirect | 125,000 | $0 | $0 | Form 4 ↗ |
| Mar 31, 2025Filed Apr 2, 2025 | Donhauser Peter D.O.Director | Grant Or AwardDirect | 50,000 | $0 | $0 | Form 4 ↗ |
| Mar 31, 2025Filed Apr 2, 2025 | Ma JiongDirector | Grant Or AwardDirect | 50,000 | $0 | $0 | Form 4 ↗ |